Rohit Sukumar

904 total citations
8 papers, 743 citations indexed

About

Rohit Sukumar is a scholar working on Biomaterials, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rohit Sukumar has authored 8 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomaterials, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rohit Sukumar's work include Nanoparticle-Based Drug Delivery (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and RNA Interference and Gene Delivery (2 papers). Rohit Sukumar is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and RNA Interference and Gene Delivery (2 papers). Rohit Sukumar collaborates with scholars based in United States, Netherlands and Germany. Rohit Sukumar's co-authors include Andrew Z. Wang, Michael E. Werner, Natalie D. Cummings, Edina C. Wang, Manish Sethi, Shrirang Karve, Jonathan A. Copp, Ronald C. Chen, Dominic T. Moore and Tian Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Rohit Sukumar

8 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rohit Sukumar United States 8 437 372 246 122 102 8 743
Natalie D. Cummings United States 7 392 0.9× 348 0.9× 230 0.9× 118 1.0× 86 0.8× 13 672
Remon Bazak Egypt 7 507 1.2× 467 1.3× 364 1.5× 77 0.6× 145 1.4× 13 915
Jueun Jeon South Korea 18 316 0.7× 482 1.3× 269 1.1× 89 0.7× 174 1.7× 27 913
Dennis Huang United States 10 303 0.7× 455 1.2× 244 1.0× 82 0.7× 112 1.1× 14 763
Abhalaxmi Singh India 12 544 1.2× 472 1.3× 235 1.0× 89 0.7× 171 1.7× 14 925
Eunji Jang South Korea 14 283 0.6× 307 0.8× 266 1.1× 73 0.6× 153 1.5× 32 730
Yaohua Wei China 18 405 0.9× 351 0.9× 326 1.3× 51 0.4× 100 1.0× 32 851
Gregory J.R. Charrois Canada 11 678 1.6× 443 1.2× 473 1.9× 91 0.7× 89 0.9× 12 1.1k
Jingxing Si China 14 292 0.7× 402 1.1× 297 1.2× 88 0.7× 150 1.5× 31 856

Countries citing papers authored by Rohit Sukumar

Since Specialization
Citations

This map shows the geographic impact of Rohit Sukumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohit Sukumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohit Sukumar more than expected).

Fields of papers citing papers by Rohit Sukumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohit Sukumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohit Sukumar. The network helps show where Rohit Sukumar may publish in the future.

Co-authorship network of co-authors of Rohit Sukumar

This figure shows the co-authorship network connecting the top 25 collaborators of Rohit Sukumar. A scholar is included among the top collaborators of Rohit Sukumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohit Sukumar. Rohit Sukumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Rocca, Joseph Della, Michael E. Werner, Rachel C. Huxford‐Phillips, et al.. (2014). Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy. Nanomedicine Nanotechnology Biology and Medicine. 11(1). 31–38. 69 indexed citations
2.
Sethi, Manish, Rohit Sukumar, Shrirang Karve, et al.. (2014). Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity. Nanoscale. 6(4). 2321–2327. 77 indexed citations
3.
Werner, Michael E., Natalie D. Cummings, Manish Sethi, et al.. (2013). Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 86(3). 463–468. 194 indexed citations
4.
Wang, Andrew Z., Natalie D. Cummings, Manish Sethi, et al.. (2013). Preclinical evaluation of genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer.. Journal of Clinical Oncology. 31(15_suppl). e13546–e13546. 36 indexed citations
5.
Karve, Shrirang, Michael E. Werner, Rohit Sukumar, et al.. (2012). Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery. Proceedings of the National Academy of Sciences. 109(21). 8230–8235. 106 indexed citations
6.
Werner, Michael E., Shrirang Karve, Rohit Sukumar, et al.. (2011). Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials. 32(33). 8548–8554. 140 indexed citations
7.
Werner, Michael E., Jonathan A. Copp, Shrirang Karve, et al.. (2011). Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy. ACS Nano. 5(11). 8990–8998. 107 indexed citations
8.
Karve, Shrirang, Michael E. Werner, Natalie D. Cummings, et al.. (2011). Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique. Journal of Visualized Experiments. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026